Pfizer faces another year of revenue decline in 2026, as Covid and loss-of-exclusivity headwinds weigh on top line growth.

Discover why Saba Closed-End Funds ETF is rated Buy for steady income and long-term growth. Click to explore CEFS and its 8.2 ...

Apple's valuation has drifted into territory that makes even some long-time fans uneasy, with the stock now priced at more ...

Historically, pricey markets have generated weaker 10-year average annual returns. It means investors must be more mindful of ...

Creates a scaled, high performing regional bank with $23 billion in assets strategically located in attractive New Jersey, Long Island and New York marketsMeaningfully enhances profitability metrics ...

Wells Fargo just kicked off coverage on Arcellx (ACLX), zeroing in on its experimental CAR T therapy for multiple myeloma as a potential future treatment backbone and putting the company more firmly ...

Gold is a widely recognized store of value, so it's a popular hedge against inflation, political issues, and economic uncertainty. The yellow metal has rocketed higher by 67% in 2025, and I think its ...